Reoperative surgery for prostate cancer

Christopher Amling, Douglass Clayton

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The best treatment for prostate cancer is an individualized choice specific to each patient. The decision to undergo prostate cancer surgery is based on several factors including the patient's preoperative health status, ability to gain oncologic control, and the patient's previous surgical history. When considering a patient for radical prostatectomy (RP), previous prostate surgery must be considered. Reoperative surgery for prostate cancer can be associated with technical challenges that may impact the long-term functional and oncologic outcomes. Previous prostate procedures can vary from treatment of benign prostatic hyperplasia (BPH) to primary local therapy for prostate cancer. Thus, one must be aware of the added challenges and risks that such surgical history portends and relate this information to the patient prior to radical prostatectomy. In this chapter, we seek to outline how previous prostate surgery impacts the technical aspects and outcomes of both primary and salvage radical prostatectomy in patients with adenocarcinoma of the prostate.

Original languageEnglish (US)
Title of host publicationReoperative Pelvic Surgery
PublisherSpringer New York
Pages81-92
Number of pages12
ISBN (Print)9780387899985
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Prostate
Prostatectomy
History
Prostatic Hyperplasia
Health Status
Adenocarcinoma
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Amling, C., & Clayton, D. (2009). Reoperative surgery for prostate cancer. In Reoperative Pelvic Surgery (pp. 81-92). Springer New York. https://doi.org/10.1007/b14187_9

Reoperative surgery for prostate cancer. / Amling, Christopher; Clayton, Douglass.

Reoperative Pelvic Surgery. Springer New York, 2009. p. 81-92.

Research output: Chapter in Book/Report/Conference proceedingChapter

Amling, C & Clayton, D 2009, Reoperative surgery for prostate cancer. in Reoperative Pelvic Surgery. Springer New York, pp. 81-92. https://doi.org/10.1007/b14187_9
Amling C, Clayton D. Reoperative surgery for prostate cancer. In Reoperative Pelvic Surgery. Springer New York. 2009. p. 81-92 https://doi.org/10.1007/b14187_9
Amling, Christopher ; Clayton, Douglass. / Reoperative surgery for prostate cancer. Reoperative Pelvic Surgery. Springer New York, 2009. pp. 81-92
@inbook{d2e1e2fbd4f74bbeb290b7ddb8fd508e,
title = "Reoperative surgery for prostate cancer",
abstract = "The best treatment for prostate cancer is an individualized choice specific to each patient. The decision to undergo prostate cancer surgery is based on several factors including the patient's preoperative health status, ability to gain oncologic control, and the patient's previous surgical history. When considering a patient for radical prostatectomy (RP), previous prostate surgery must be considered. Reoperative surgery for prostate cancer can be associated with technical challenges that may impact the long-term functional and oncologic outcomes. Previous prostate procedures can vary from treatment of benign prostatic hyperplasia (BPH) to primary local therapy for prostate cancer. Thus, one must be aware of the added challenges and risks that such surgical history portends and relate this information to the patient prior to radical prostatectomy. In this chapter, we seek to outline how previous prostate surgery impacts the technical aspects and outcomes of both primary and salvage radical prostatectomy in patients with adenocarcinoma of the prostate.",
author = "Christopher Amling and Douglass Clayton",
year = "2009",
doi = "10.1007/b14187_9",
language = "English (US)",
isbn = "9780387899985",
pages = "81--92",
booktitle = "Reoperative Pelvic Surgery",
publisher = "Springer New York",

}

TY - CHAP

T1 - Reoperative surgery for prostate cancer

AU - Amling, Christopher

AU - Clayton, Douglass

PY - 2009

Y1 - 2009

N2 - The best treatment for prostate cancer is an individualized choice specific to each patient. The decision to undergo prostate cancer surgery is based on several factors including the patient's preoperative health status, ability to gain oncologic control, and the patient's previous surgical history. When considering a patient for radical prostatectomy (RP), previous prostate surgery must be considered. Reoperative surgery for prostate cancer can be associated with technical challenges that may impact the long-term functional and oncologic outcomes. Previous prostate procedures can vary from treatment of benign prostatic hyperplasia (BPH) to primary local therapy for prostate cancer. Thus, one must be aware of the added challenges and risks that such surgical history portends and relate this information to the patient prior to radical prostatectomy. In this chapter, we seek to outline how previous prostate surgery impacts the technical aspects and outcomes of both primary and salvage radical prostatectomy in patients with adenocarcinoma of the prostate.

AB - The best treatment for prostate cancer is an individualized choice specific to each patient. The decision to undergo prostate cancer surgery is based on several factors including the patient's preoperative health status, ability to gain oncologic control, and the patient's previous surgical history. When considering a patient for radical prostatectomy (RP), previous prostate surgery must be considered. Reoperative surgery for prostate cancer can be associated with technical challenges that may impact the long-term functional and oncologic outcomes. Previous prostate procedures can vary from treatment of benign prostatic hyperplasia (BPH) to primary local therapy for prostate cancer. Thus, one must be aware of the added challenges and risks that such surgical history portends and relate this information to the patient prior to radical prostatectomy. In this chapter, we seek to outline how previous prostate surgery impacts the technical aspects and outcomes of both primary and salvage radical prostatectomy in patients with adenocarcinoma of the prostate.

UR - http://www.scopus.com/inward/record.url?scp=84892081317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892081317&partnerID=8YFLogxK

U2 - 10.1007/b14187_9

DO - 10.1007/b14187_9

M3 - Chapter

AN - SCOPUS:84892081317

SN - 9780387899985

SP - 81

EP - 92

BT - Reoperative Pelvic Surgery

PB - Springer New York

ER -